Folgen
-
Vishnu, the CEO of Paradigm IT Cybersecurity, discusses the unique challenges of cybersecurity in the healthcare industry in India. He highlights that healthcare is one of the most targeted sectors for cyber attacks, with valuable data being a major motivation for attackers. He emphasizes the need for strict access control, compliance, and phishing training to prevent attacks. Vishnu also mentions the lack of investment in cybersecurity in the healthcare sector and the potential risks associated with digitization and remote care. He recommends implementing cybersecurity frameworks, employee training, investing in cybersecurity technologies, data access controls, instant response plans, software updates, and strong third-party vendor agreements.
00:00 Intro
00:30 Whats different about cybersec in healthcare
04:09 What low-risk, high-reward
05:00 Cybersec IS an expensive afterthought so...
07:18 How is Indian healthcare responding to cybersecurity?
09:00 Thoughts on a separate health data law?
10:20 New-age care delivery
12:58 Higher chance of a cyber-attack
14:20 Check-list to assess capabilities against a cyber-attack -
Back in 2021, Akash Parvatikar Co-authored a paper titled - 'Prototypical models for classifying high-risk atypical breast lesions'. The premise was that some breast lesions are particularly challenging to classify, leading to different pathologists making different diagnoses based on the same information. The paper aimed to reduce this variability by providing a consistent computational method.
A key contribution of this work is that the AI model can explain its recommendations in a way that is useful for clinical practice. This is important because doctors need to understand why an AI system has made a particular diagnosis to trust and act on its recommendations.
In this episode, Akash discusses his work in relation to xAI in diagnosing breast cancer. He discusses the model he developed, which outperformed baseline models in detecting high-risk breast lesions. Akash emphasizes the importance of xAI in building trust and transparency in clinical decision-making tools and explains how his model incorporates explainability through feature detection and contribution scores.
Akash emphasizes the need for explanations to be provided frequently to end users, as it plays a crucial role in building trust in AI systems. He also highlights the importance of involving domain experts in the development of AI models.
0:00 Intro
1:29 Achieving consistent diagnosis is crucial in patient care
4:45 Why does non-uniformity in diagnosis exist in among pathologists
9:40 What were the considerations for model preparation?
14:04 Components of the model and how they incorporate explainability
17:17 How explanation was incorporated - a simplified analogy
22:52 How does xAI manifest itself for pathologists?
26:54 Should explainability be a feature across all AI models in healthcare?
29:29 So explainability in drug discovery is pointless?
31:00 Frequency of explainability
33:51 Domain experts need to be in the loop when building AI models
36:00 Outro
You can reach out to Akash on his LinkedIn at - https://www.linkedin.com/in/akash007/ -
Fehlende Folgen?
-
In this episode, Srikrishna Seshadri shares insights into the design and implementation of care coordination and data aggregation solutions at Tata Consultancy Services (where he was a product manager). The implementation of the Tata Digital Nerve Center, a centralised capacity management center, is highlighted as a successful model for improving healthcare delivery. The key takeaways include the importance of innovation in healthcare delivery, the need for coordination and partnerships, and the value of technology in improving patient outcomes.
He also talks about Previu Health's (a new healthtech company he is a co-founder in) focus on preventive healthcare and the potential of technologies like Google MedPalm 2 in improving public health outcomes.
0:00 Intro
0:34 Does Bengaluru 'Bangalore' even for tech in healthcare?
1:12 Investment Trends in HealthTech startups that catch his eye
3:25 Care Co-ordination and Data Aggregation - A monologue (high value)
17:10 Care Co-ordination from a population health standpoint cannot have vested interests
20:05 Point of care devices will play a huge role for care co-ordination at capacity (say rural health camps)
24:23 How will AI play a role at Previu?
29:53 Google MedPalm 2's role in public health will be evaluated from specific use cases
35:36 Outro -
Nitesh heads product development and commercialisation at InAccel (a medical device company from India), and has been referred to as a trailblazer by the Royal College of Engineering.
In this episode, Nitesh discusses his background and role within InAccel. He shares his experience with the Stanford India BioDesign Program and how it shaped his approach to health technology innovation. Nitesh explains the process of identifying critical unmet needs (in the Indian and global healthcare space) and prioritising which problems to tackle through medical device innovation. He also discusses the journey from identifying a healthcare need to bringing a regulatory certified product to market, using VapCare as a case study. Nitesh also shares his perspective on the FDA and CE Mark regulatory pathways and his vision for making India a manufacturing hub for medical devices.
He also provides advice for innovators in health tech and discusses building for different market segments. Nitesh highlights the impact of his work and the recognition he has received for his contributions to healthcare.
1:24 What does it mean to get into product development and commercialisation for med devices?
2:23 Experience with Stanford India BioDesign Programme
4:18 Unmet critical needs - how to prioritise them and evaluate prospective impact?
5:38 Regulatory pathways as a lens to evaluate creation of a medical device?
6:31 Volume of medical needs requiring solutions that don't need higher regulatory pathways
7:14 Top 2 filters to assess unmet critical medical needs
9:30 Journey from identifying a healthcare need to bringing a regulatory certified product to market
18:04 Preference between #CE Mark and #fda
19:56 The amended UK MDR
21:06 FDA clearance helps enter other developing nations
22:10 Regulating #ai - screening versus diagnostic - brief thoughts
23:50 Hopes from and working with Indian regulators
24:45 VapCare - Process of demonstrating product efficacy and safety
29:17 Medical device developed. Now how to ensure effective implementation?
Reach Nitesh via his LinkedIn here: https://www.linkedin.com/in/nitesh-ku... -
Dr. Jaideep Rayapudi is the VP of Clinical Solutions at Precognitas, an #ai #healthcare company that offers its solutions to organisations and care communities in the US. But he also pushes for digital health adoption in India. He's well placed to provide a critical and unique perspective of the same and he discusses the role of AI-driven solutions in healthcare and the challenges and opportunities in the Indian healthcare ecosystem.
He compares the healthcare infrastructure and technology adoption in the US and India, highlighting the solid base of digital infrastructure being built under the #abdm and how that already puts us in an advantageous position.
Having said that, Dr. Jaideep points out the importance of education and mindset change in the medical community to drive technology adoption. This, he says, is the biggest barrier to adopting digital solutions and is not a problem that can be solved easily.
0:00 Dr. Jaideep wants to will tech adoption for healthcare in India - true?
1:40 healthcare analytics and AI to provides better community care in the US
3:30 Impact of work in the US and #sdoh
5:46 India vs US in terms of healthcare infra, data avb. and tech adoption
8:51 Problems of data infrastructure are similar in India and the US
11:46 Fear of the unknown and tech adoption in healthcare
14:39 Transcribing software is symptomatic of rotten UX and not upto standard use cases
17:25 Strength and weakness of AI application in Indian healthcare
20:00 Digital infra or Digital mindset - biggest blocker to tech adoption?
23:34 Concern is the doctor who is in the 30's / 40's age group
26:24 Balancing | 100 + patients a day vs tech adoption headaches
30:00 An AI application that holds most amount of promise in India
31:15 Google Gemini and a healthcare business
Dr. Jaideep comes across as someone who is revolutionary in his thinking and provided perspectives on #ai and #healthtech in India that I have not heard before.
He can be reached on LinkedIn here: https://www.linkedin.com/in/jdrayapudi/ -
In this episode of 'The HealthTech Narrative Podcast' Bhavesh Hemani, Group CFO at 2070 Health and W Health Ventures, puts his CFO hat on, and brings 2 decades of his experience to talk about what #healthtech startups should be thinking about when building for India and the world. Hear what a CFO has to say on all things #digitalhealth.
He, discusses the venture studio model and the support and resources that #healthtech entrepreneurs can expect from partnering with 2070 Health. He explains the equity arrangements and resource contributions made by 2070 Health, and what could make them restructure any equity arrangement at a later stage.
Hear Bhavesh's thoughts on building in / for rural / urban India. 2070 Health works with #digitalhealth startups catering to both, emerging and established markets - hear what he has to say on the important points to consider when working with such startups. In the Phy-gital (read omni-channel) space, what role does the digital play?
Bhavesh discusses the challenges and opportunities of investing in R&D-intensive startups and the risk management strategies for investing in emerging markets. He concludes by emphasising the importance of passion and shared vision in founders.
0:00 Introduction
0:26 The Venture Studio Model of 2070 Health
5:34 How does 2070 approach equity arrangements and resource provision?
7:42 Open to re-structuring equity arrangements at a later stage?
9:55 Financial Indicators and Investment Decisions
13:09 What Bhavesh means by 'Pace at which you scale'
15:45 Rural Vs. Urban - where is it more expensive to build and deploy?
18:20 International Operations and Building From India
24:46 Integrating Digital and Physical Healthcare
27:30 Data Privacy Laws and Cost Compliance
30:39 Desirable traits in #healthtech founders
33:50 HEAR THIS IF YOU WANT TO PARTNER WITH 2070 :) -
Shalini Aggarwal, a postdoctoral researcher at the Weizmann Institute of Science, discusses her work on gene cards and using AI to diagnose malaria. Shalini shares her journey of using AI in disease diagnosis and the importance of digital health records. She also discusses the integration of AI in educational institutions and the need for collaboration with hospitals. The conversation concludes with a discussion on patents and the impact of her research.
Reach out to Shalini at:
LinkedIn: https://www.linkedin.com/in/shaliniag...
Email: [email protected]
00:00 Introduction
03:39 Why choose Malaria?
06:03 Break Down Steps and Milestones of the Research
10:01 What was the reason for using AI incidentally?
13:07 Pros and Cons of using AI to diagnose Malaria?
16:43 Thoughts on solutions to the cons
18:53 Summary of Israel and UK scenarios on health records
20:13 Perspective on use of AI in educational institutions
24:29 Partnerships remove barriers to collaboration
25:54 Patents and Takeaways -
Sohit is the Co-Founder of HealthTech Startup - DRiefcase.
DRiefcase is a digital health platform that aims to revolutionize India's healthcare landscape. The company's vision is to provide a trusted platform for users to manage their health information. One of the key features of DRiefcase is the rapid retrieval of medical records, which plays a crucial role in medical emergencies. The platform allows users to find any record in less than 10 seconds, reducing the administrative stress in critical situations.
In this Episode Sohit talks about:
1. The vision and aim of Driefcase
2. The labour intensive process that digital health is in terms of a business
3. Important stakeholders for DRiefcase
4. The benefits of a health locker
5. DRiefcase's MOAT
6. Penetration in Rural vs Cities
7. How DRiefcase is synonymous with the ABDM
8. The seriousness with which DRiefcase takes patient privacy
9. His advise to healthtech innovators
If you are interested in collaborating with DRiefcase, please reach out to me at [email protected] and I will set it up! -
Welcome to Part I of our insightful conversation with Dr. Indu Bhushan, a visionary leader in global health and former CEO of Ayushman Bharat. In this episode, we delve into Dr. Bhushan's remarkable career journey - from his roots as an IIT graduate in Electrical and Electronics Engineering to his transition into the world of public health, navigating roles as diverse as an Indian Administrative Service officer, World Bank professional, Asian Development Bank veteran, to helming one of the largest healthcare initiatives in the world.
The discussion provides a unique perspective into the complexities of healthcare systems, exploring various models for managing healthcare expenses. Dr. Bhushan's expertise in health economics shines through as he elucidates on these issues, shedding light on his experiences and the lessons learned along the way.
A highlight of this episode is Dr. Bhushan's fascinating account of his experience with China and how the country leveraged the SARS outbreak to advance its digital health agenda. The takeaways from this part of our discussion are profound, shedding light on the role of public health crises in catalyzing health innovation and systemic change.
Stay tuned for Part II where we continue our deep-dive into Dr. Bhushan's insights on health economics, digital health, and the future of healthcare in India. Don't forget to like, share, and subscribe for more compelling conversations about health technology
-
Speech therapy for so long has been about undergoing many one-to-one sessions with a therapist, with the added condition of a high cost. More over, the lack of training and stigma to not being able to speak well, coupled with the lack of access to competent speech therapists has resulted in a situation where speech therapy is an oft ignored problem.
Not for digital health and certainly not for Stamurai. In this episode we speak to Mr. Meet Singhal, Co-Founder of Stamurai. In this episode you will hear:
1. What Stamurai is, and how it automates for interventions for speech therapy.
2. The tools used by Stamurai to automate.
3. The journey of the co-founders and what motivated them to solve for speech disorders.
4. How doctor consultations work on the Stamurai ecosystem, along with how the tech provides for such consultations to be more meaningful.
5. The role of evidence and data to create a feedback loop to improve an offering such as this.
6. Learnings from teleconsultation in relation to digital speech therapy.
7. Stamurai's domestic and global audience.
8. Pan-India action plan.
You can learn more about Stamurai at: https://stamurai.com/
Connect with Meet at: https://www.linkedin.com/in/meet-singhal-39258160/ -
In this episode, we speak to Dr. Arbinder Singal, a Pediatric Urologist, and CEO of Fitterfly. Fitterfly is an Indian DTx healthtech startup that seeks to prevent, manage and treat certain lifestyle diseases like diabetes, PCOS/PCOD, obesity et al. In this episode hear Dr. Arbinder talk about:
1. What Fitterfly does.
2. What does the customer/patient journey look like on Fitterfly's platform.
3. What the last round of funding means for Fitterfly and what it plans to do with the same.
4. How Fitterfly solves for the patient side non-adherence problem.
5. The different products from Fitterfly's stable and how they optimised for COVID.
6. The tech stack layer that makes up Fitterfly.
7. Dr. Arbinders thoughts on AI and its role at Fitterfly currently, and in the future.
8. The nutrition database & software business vertical part of Fitterfly, and what went into making it India's biggest nutrition database, relied on by companies like Nestle, Abbot, Sun Pharma, Swiggy, to name a few.
You may reach out to the host at: [email protected]
Reach out to Dr. Arbinder at: https://www.linkedin.com/in/arbinder-singal-265b9919/
Check out Fitterfly at: https://www.fitterfly.com/
-
Fedo is an Insurtech startup leveraging its tech or the benefit of health and life insurance companies in India and the world. Its proprietary Fedo Score is an AI based health score that provides a snapshot of the overall health of an individual. Insurers can use the Fedo Score to assess the extent of coverage an individual could be provided.
Fedo, through its AI/ML based engine, also helps health and life insurance companies to automate and make more effective the underwriting process, a key primary activity for any insurance company. Key benefits to insurers include cost efficiencies and data accuracy allowing insurers to make better decisions.
Arun breaks down the need for a service like Fedo, not only for the insurance market but also for the digital health space overall, while covering the future plans for Fedo, which involve moving beyond just the insurance space.
Find out more about Fedo at: https://www.fedo.ai/
Connect with Arun Mallavarapu at: https://www.linkedin.com/in/arunmallavarapu/ -
In this episode, we talk to Suthirth Vaidya, the CEO and Co-Founder of Predible Health. Predible Health is a healthtech startup that uses AI to measure abnormalities within the body seeking to not only make the work of radiologists easier, but also to provide a quicker, effective, efficient and more accurate diagnosis. What started out as a cancer radiology platform, quickly evolved into products for scanning and diagnosing issues within the lung and liver. More recently, Predible has used its AI to help medical practitioners effectively and in a timely manner, diagnose patients affected by the COVID 19 virus.
-
In this episode, we speak to Arvind S.A., Co-Founder, Flexmotiv. Flexmotiv is a biomechanical product design and manufacturing healthtech startup, which uses technology to manufacture pain free and slip resistant crutches empowering people with limited mobility to be independent, and literally be mobile, anywhere! Along with the journey of Flexmotiv, Arvind also talks about the need for such assistive care products, especially in India. The products made by this startup target India's problem of not being necessarily friendly to people with disabilities, as well as assist those part of India's ageing population.
-
In this episode, Divyam provides an insight into the NHA's NDHM which aims to be the blueprint for the how the digital health ecosystem in India develops. This episode provides insights into the architecture and building blocks that would make up the NDHM and exposits on certain key concepts including the FHIR interoperability standards.
You may reach out to Divyam at: [email protected] -
In this episode, Divyam speaks about the history of India's healthcare with an overview of the state of India's healthcare system, how healthcare objectives have changed over time and the governance and financing of healthcare in India.
You may reach out to Divyam at: [email protected] -
In this episode, Divyam provides an introduction to himself, his work and most importantly, what this podcast will be about. He then goes on to speak about certain aspects of the HealthTech Startup space in India and why we should be excited about the same.
You may reach out to Divyam at: [email protected]
